Accepted at 5:03 p.m. Oct, 31, 2023 by Alex
Author: akufta
Related Note: 1473995163159 1
Rationale for change

Extra section: Thrombin also activates IIa (itself), V, VIII, and XIII 5 + 8 = 13

verified it's not fator 11 but 13 through a few sources

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
Changed Tags
#AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::Primary_Hemostasis::Platelets
#AK_Step1_v12::#NinjaNerd::03_Microbiology::01_Basics::02_Endotoxins_vs._Exotoxins #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::01_Coagulation_Cascade #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::02_Coagulopathy #AK_Step1_v12::#UWorld::Step::941 #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::03_Physiology::05_Coagulation_and_kinin_pathways::*Coagulation_Cascade #AK_Step1_v12::#NinjaNerd::09_Hematology::02_Pathology::15_Antiplatelets,_Anticoagulants,_and_Thrombolytics #AK_Step1_v12::#SketchyPath::09_Blood_&_Coagulation::03_Coagulopathies_&_Platelet_Disorders::05_Acquired_&_Inherited_Thrombosis_Syndromes #AK_Other::AnKing_Image::Aiman #AK_Step1_v12::#NinjaNerd::06_Cardiovascular::04_Pharmacology::02_Warfarin_(MOA,_Indications,_AR,_CI) #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Other::AnKing_Image::!Subjects::Hematology::Coagulation_Cascade #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::03_Antiplatelet,_Anticoagulant,_Thrombolytic_Agents #AK_Step1_v12::#Pixorize::01_Biochemistry::17_Coagulation::01_Common_Pathway_of_Coagulation #AK_Step1_v12::#NinjaNerd::09_Hematology::02_Pathology::18_Coagulopathy #AK_Step1_v12::#UWorld::COMLEX::24053 #AK_Step1_v12::^Systems::HemeOnc::Hematology #AK_Other::AnKing_Image::Aiman::Coagulation_Cascade #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::02_Secondary_Hemostasis #AK_Step1_v12::#NinjaNerd::09_Hematology::01_Physiology::07_Hemostasis:_Coagulation_Cascade #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::01_Bleeding_&_Clotting_Disorders::01_Bleeding_Disorders:_Coagulation_Factor_Disorders_DDx #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::16_Coagulation_disorders::*Coagulation_Cascade #AK_Step1_v12::#SketchyPhysiology::10_Hematology::01_Blood_Components_&_Function::01_Coagulation_Cascade #AK_Other::Only_Step_1 #AK_Step1_v12::#NinjaNerd::06_Cardiovascular::04_Pharmacology::03_Heparin_(MOA,_Indications,_ADR,_CI) #AK_Step1_v12::#Pathoma::04_Hemostasis::02_Secondary_Hemostasis_&_Related_Disorders #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::01_Coagulation #AK_Step1_v12::#Physeo::^physeo_image_update #PANCE::HEME::coagulation_disorders #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_Hematology #AK_Step1_v12::#Low/HighYield::1-HighYield